BLK
57
3
R
65
2
KLAC
58
-5
CA
12
-8
EMR
37
-2
LNC
45
2
SWK
77
4
ES
38
2
MET
43
6
ADP
62
4
FTI
81
-3
AVGO
37
-5
SWKS
38
-15
DLTR
42
2
DE
30
-2
ZION
52
4
GOOG
87
4
AES
57
11
EQT
53
-6
NTRS
29
2
BLK
57
3
R
65
2
KLAC
58
-5
CA
12
-8
EMR
37
-2
LNC
45
2
SWK
77
4
ES
38
2
MET
43
6
ADP
62
4
FTI
81
-3
AVGO
37
-5
SWKS
38
-15
DLTR
42
2
DE
30
-2
ZION
52
4
GOOG
87
4
AES
57
11
EQT
53
-6
NTRS
29
2
Financhill
Back

Olympus Vs. Nxera Pharma Industry Stock Comparison

Sell
31

OCPNF
Olympus

Last Price:
13.86
Seasonality Move:
7.74%
Sell
16

SOLTF
Nxera Pharma

Last Price:
9.30
Seasonality Move:
15.46%
Sell
31
Olympus (OCPNF) is a Sell

Is Olympus a Buy, Sell or Hold?

  • The current Olympus [OCPNF] share price is $13.86. The Score for OCPNF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • OCPNF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
Nxera Pharma (SOLTF) is a Sell

Is Nxera Pharma a Buy, Sell or Hold?

  • The current Nxera Pharma [SOLTF] share price is $9.30. The Score for SOLTF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • SOLTF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OCPNF Stock Price Chart

What is Olympus's stock price today?

  • The Olympus share price today is $13.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCPNF is experiencing slight buying pressure.

SOLTF Stock Price Chart

What is Nxera Pharma's stock price today?

  • The Nxera Pharma share price today is $9.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOLTF is experiencing slight buying pressure.

OCPNF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 38.93 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.92 - 14.4) Sell
Bollinger Bands (100): (14 - 14.74) Sell

SOLTF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 30.53 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.54 - 10.48) Sell
Bollinger Bands (100): (9.25 - 10.81) Sell

OCPNF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.97 Sell
20-day SMA: 14.09 Sell
50-day SMA: 14.24 Sell
200-day SMA: 14.13 Sell
8-day EMA: 13.98 Sell
20-day EMA: 14.09 Sell
50-day EMA: 14.21 Sell
200-day EMA: 14.68 Sell

SOLTF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.51 Sell
20-day SMA: 9.88 Sell
50-day SMA: 10.09 Sell
200-day SMA: 10.29 Sell
8-day EMA: 9.49 Sell
20-day EMA: 9.79 Sell
50-day EMA: 9.99 Sell
200-day EMA: 10.9 Sell

Olympus Earnings Growth & OCPNF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nxera Pharma Earnings Growth & SOLTF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Olympus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nxera Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):